IP Library Granted Patent US 7,462,465
Granted Patent B2
US 7,462,465 · App. 09/798,584 · Granted Dec 9, 2008

Nucleic acid encoding KCNB potassium channel

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,462,465
App. No.
09/798,584
Granted
Dec 9, 2008
Kind
B2
Abstract

The present invention provides nucleic acid and protein sequences for a novel potassium channel protein, KCNB. The herein-disclosed sequences can be used for any of a number of purposes, including for the specific detection of KCNB, for the identification of molecules that associate with and/or modulate the activity of KCNB, to diagnose any of a number of conditions associated with KCNB or KCNB activity, or to modulate the number or activity of KCNB molecules in a mammal.

Claims (15)

1. An isolated nucleic acid encoding a potassium channel polypeptide that transduces a change in membrane potential, wherein the polypeptide comprises 90% or greater identity to the amino acid sequence of SEQ ID NO:1.

2. The isolated nucleic acid of claim 1 , wherein the polypeptide comprises greater than 95% amino acid sequence identity to the amino acid sequence of SEQ ID NO:1.

3. The isolated nucleic acid of claim 1 , wherein the nucleic acid encodes a polypeptide that specifically binds to polyclonal antibodies generated against an amino acid sequence of SEQ ID NO:1.

4. An isolated nucleic acid encoding a protein comprising an amino acid sequence of SEQ ID NO:1.

5. An isolated nucleic acid comprising a nucleotide sequence of SEQ ID NO:2 or the protein coding region set forth in SEQ ID NO:5.

6. The isolated nucleic acid of claim 1 , wherein the nucleic acid is amplified by a primer pair selected from the group consisting of SEQ ID NO:6 and SEQ ID NO:7; and SEQ ID NO:9 and SEQ ID NO:10.

7. An isolated nucleic acid encoding a potassium channel polypeptide that transduces a change in membrane potential and comprises 90% or greater identity to the amino acid sequence of SEQ ID NO:1, wherein the nucleic acid selectively hybridizes under stringent hybridization conditions comprising 50% formamide, 5×SSC and 1% SDS at 42° C. and wash conditions comprising 0.2×SSC and 0.1% SDS at 65° C. to a nucleotide sequence of SEQ ID NO:2 or SEQ ID NO:5.

8. An isolated nucleic acid encoding a potassium channel polypeptide that transduces a change in membrane potential, wherein the polypeptide comprises at least 200 contiguous amino acids of the amino acid sequence of SEQ ID NO:1.

9. An isolated nucleic acid of claim 8 , wherein the polypeptide comprises two pore domains and four transmembrane domains as set forth in FIG. 1 .

10. An expression vector comprising the nucleic acid of claim 1 , claim 4 , claim 5 , claim 7 , or claim 8 .

11. A host cell transfected with the vector of claim 10 .

12. A method of making a potassium channel polypeptide, the method comprising the step of expressing the polypeptide from a recombinant expression vector comprising a nucleic acid encoding the polypeptide, wherein the amino acid sequence of the polypeptide comprises 90% or greater amino acid identity to SEQ ID NO:1 and the encoded polypeptide transduces a change in membrane potential.

13. A method of making a recombinant cell comprising a potassium channel polypeptide, the method comprising the step of transducing the cell with an expression vector comprising a nucleic acid encoding the polypeptide, wherein the amino acid sequence of the polypeptide comprises 90% or greater amino acid identity to SEQ ID NO:1 and the encoded polypeptide transduces a change in membrane potential.

14. An isolated nucleic acid, or complement thereof, comprising at least 50 contiguous nucleotides of SEQ ID NO:2 or SEQ ID NO:5.

15. An isolated nucleic acid, or complement thereof, comprising at least 100 contiguous nucleotides of SEQ ID NO:2 or SEQ ID NO:5.

Assignments (5)
MERGER Recorded Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
CHANGE OF NAME Recorded Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →
MERGER Recorded Apr 22, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 015937/0104 →
CHANGE OF NAME Recorded Apr 22, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 015937/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 015937/0155 →